September 8, 2023 Comments Off on New patent for Tarsus drug XDEMVY Posted in: Patent Added Annual Drug Patent Expirations for XDEMVY Xdemvy is a drug marketed by Tarsus and is included in one NDA. It is available from one supplier. The generic ingredient in XDEMVY…
The post New patent for Tarsus drug XDEMVY appeared first on DrugPatentWatch …
September 8, 2023 Comments Off on New patent for MC2 drug WYNZORA Posted in: Patent Added Annual Drug Patent Expirations for WYNZORA Wynzora is a drug marketed by MC2 and is included in one NDA. It is available from one supplier. There are two patents protecting…
The post New patent for MC2 drug WYNZORA appeared first on DrugPatentWatch – M…